A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis

Vancomycin-resistance Transferability from VanA Enterococci to Staphylococcus aureus

(2011) Simona de Niederhäusern et al.   CURRENT MICROBIOLOGY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens

(2010) Henry S. Fraimow et al.   CRITICAL CARE CLINICS

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Updated Functional Classification of  -Lactamases

(2009) K. Bush et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid assessment of the effect of ciprofloxacin on chromosomal DNA from Escherichia coli using an in situ DNA fragmentation assay

(2009) María Tamayo et al.   BMC MICROBIOLOGY

Rapid and Simple Determination of Ciprofloxacin Resistance in Clinical Strains of Escherichia coli

(2009) R. Santiso et al.   JOURNAL OF CLINICAL MICROBIOLOGY

DNA Fragmentation in Microorganisms Assessed In Situ

(2008) J. L. Fernandez et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Molecular Control of Bacterial Death and Lysis

(2008) K. C. Rice et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS